“…Nevertheless, over the past few years, the metabolomics approach in terms of thyroid diagnosis has shown an enormous evolution, which is due, in part, to the application of several analytical techniques that allow the study of the complete set of small biomolecules that make up a biological sample. The main metabolomics techniques that have mostly been adopted in the thyroid, in an attempt to identify biomarkers, classify the thyroid cancer, facilitate an earlier diagnosis and prevent the development and invasion at the systemic level of the cancer itself, are Mass Spectrometry (MS) [53][54][55], Nuclear Magnetic Resonance (NMR) [53,56,57], Raman Spectroscopy [58][59][60] and Fourier Transform Infrared (FTIR) Spectroscopy [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79]. This increase in the number of studies is attributed to the greater availability of improved and accurate metabolomics techniques that exist and also due to the development of appropriate statistical tools that are able to handle the huge amount of data resulting from the samples under analysis [80].…”